Toxicology and Epidemiology: Improving the Science with a Framework for Combining Toxicological and Epidemiological Evidence to Establish Causal Inference

被引:82
作者
Adami, Hans-Olov [1 ,2 ]
Berry, Colin L. [3 ]
Breckenridge, Charles B. [4 ]
Smith, Lewis L. [5 ,6 ]
Swenberg, James A. [7 ]
Trichopoulos, Dimitrios [1 ]
Weiss, Noel S. [8 ,9 ]
Pastoor, Timothy P. [4 ]
机构
[1] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02215 USA
[2] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden
[3] Queen Mary Univ, London, England
[4] Syngenta Crop Protect, Toxicol & Hlth Sci Dept, Greensboro, NC 27419 USA
[5] Univ Leicester, MRC, Toxicol Unit, Coll Med, Leicester, Leics, England
[6] Syngenta Crop Protect Ltd, Basel, Switzerland
[7] Univ N Carolina, Dept Environm Sci & Engn, Chapel Hill, NC 27599 USA
[8] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA
[9] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA
关键词
epidemiology; causation; framework; HUMAN RELEVANCE; REYES-SYNDROME; AFLATOXIN EXPOSURE; CARCINOGENIC MODES; IPCS FRAMEWORK; CANCER; RISK; INFORMATION; FIELDS;
D O I
10.1093/toxsci/kfr113
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Historically, toxicology has played a significant role in verifying conclusions drawn on the basis of epidemiological findings. Agents that were suggested to have a role in human diseases have been tested in animals to firmly establish a causative link. Bacterial pathogens are perhaps the oldest examples, and tobacco smoke and lung cancer and asbestos and mesothelioma provide two more recent examples. With the advent of toxicity testing guidelines and protocols, toxicology took on a role that was intended to anticipate or predict potential adverse effects in humans, and epidemiology, in many cases, served a role in verifying or negating these toxicological predictions. The coupled role of epidemiology and toxicology in discerning human health effects by environmental agents is obvious, but there is currently no systematic and transparent way to bring the data and analysis of the two disciplines together in a way that provides a unified view on an adverse causal relationship between an agent and a disease. In working to advance the interaction between the fields of toxicology and epidemiology, we propose here a five-step "Epid-Tox" process that would focus on: (1) collection of all relevant studies, (2) assessment of their quality, (3) evaluation of the weight of evidence, (4) assignment of a scalable conclusion, and (5) placement on a causal relationship grid. The causal relationship grid provides a clear view of how epidemiological and toxicological data intersect, permits straightforward conclusions with regard to a causal relationship between agent and effect, and can show how additional data can influence conclusions of causality.
引用
收藏
页码:223 / 234
页数:12
相关论文
共 50 条
[1]  
[Anonymous], ENV LAW REP
[2]  
[Anonymous], 2001, IARC Monographs on the evaluation of carcinogenic risks to humans, V79, P161
[3]   IPCS framework for analyzing the relevance of a noncancer mode of action for humans [J].
Boobis, Alan R. ;
Doe, John E. ;
Heinrich-Hirsch, Barbara ;
Meek, M. E. ;
Munn, Sharon ;
Ruchirawat, Mathuros ;
Schlatter, Josef ;
Seed, Jennifer ;
Vickers, Carolyn .
CRITICAL REVIEWS IN TOXICOLOGY, 2008, 38 (02) :87-96
[4]   IPCS framework for analyzing the relevance of a cancer mode of action for humans [J].
Boobis, Alan R. ;
Cohen, Samuel M. ;
Dellarco, Vicki ;
McGregor, Douglas ;
Meek, M. E. ;
Vickers, Carolyn ;
Willcocks, Deborah ;
Farland, William .
CRITICAL REVIEWS IN TOXICOLOGY, 2006, 36 (10) :781-792
[5]  
Cochran, 1964, PUBLIC HLTH SERVICE
[6]   The human relevance of information on carcinogenic modes of action: Overview [J].
Cohen, SM ;
Meek, ME ;
Klaunig, JE ;
Patton, DE ;
Fenner-Crisp, PA .
CRITICAL REVIEWS IN TOXICOLOGY, 2003, 33 (06) :581-589
[7]  
Colditz GA., 2006, Cancer epidemiology and prevention, V3rd
[8]  
ECETOC (European Centre for Ecotoxicology and Toxicology of Chemicals), 2009, Framework for the Integration of Human and Animal Data in Chemical Risk Assessment
[9]   NEW EPIDEMIOLOGIC EVIDENCE CONFIRMING THAT BIAS DOES NOT EXPLAIN THE ASPIRIN REYES-SYNDROME ASSOCIATION [J].
FORSYTH, BW ;
HORWITZ, RI ;
ACAMPORA, D ;
SHAPIRO, ED ;
VISCOLI, CM ;
FEINSTEIN, AR ;
HENNER, R ;
HOLABIRD, NB ;
JONES, BA ;
KARABELAS, ADE ;
KRAMER, MS ;
MICLETTE, M ;
WELLS, JA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 261 (17) :2517-2524
[10]  
GRAHAM JD, 1995, P C PROP ROL EP RISK